157 Folgen

Cardionerds is a medical cardiology podcast created to bring high yield cardiovascular concepts in a fun and engaging format for listeners of all levels.



We aim to democratize cardiovascular education, promote diversity & inclusion in our beloved field, empower every learner to teach & every teacher to learn and foster wellness & humanity for all.



Check us out! www.cardionerds.com

Cardionerds: A Cardiology Podcast CardioNerds

    • Gesundheit und Fitness
    • 4,8 • 5 Bewertungen

Cardionerds is a medical cardiology podcast created to bring high yield cardiovascular concepts in a fun and engaging format for listeners of all levels.



We aim to democratize cardiovascular education, promote diversity & inclusion in our beloved field, empower every learner to teach & every teacher to learn and foster wellness & humanity for all.



Check us out! www.cardionerds.com

    156. Lipids: Triglycerides – Pathophysiology to Clinical Outcomes with Dr. Matthew Budoff

    156. Lipids: Triglycerides – Pathophysiology to Clinical Outcomes with Dr. Matthew Budoff

    CardioNerds Dan Ambinder, Dr. Tommy Das (Program Director of the CardioNerds Academy and cardiology fellow at Cleveland Clinic), and episode lead, Dr. Teodora Donisan (CardioNerds Academy fellow and incoming Chief fellow and Beaumont Health Internal Medicine resident) join Dr. Matthew Budoff (professor of medicine at David Geffen School of Medicine at UCLA and the Endowed Chair of Preventive Cardiology at Harbor-UCLA Medical Center) for a discussion about triglycerides from pathophysiology to clinical outcomes. This episode is part of the CardioNerds Lipids Series which is a comprehensive series lead by co-chairs Dr. Rick Ferraro and Dr. Tommy Das and is developed in collaboration with the American Society For Preventive Cardiology (ASPC).







    Triglyceride (TG) metabolism can produce a by-product called remnant lipoproteins, which can be atherogenic. Most guidelines consider hypertriglyceridemia to start at values ≥ 150 mg/dl. It is the most common dyslipidemia, as it can occur in 30% of the general population. Although fasting levels are usually obtained per the current US protocol, there is evidence that non-fasting TG levels might be a better indicator of cardiovascular (CV) risk as these levels may better reflect the usual levels that the body is exposed to. There are multiple primary (genetic) causes of elevated TG, but these are rarer than lifestyle factors, medical conditions, or medications. Genetic association studies are helping better define the level of CV risk stemming from elevated TG-levels, which will impact how we target lifestyle and treatment interventions in the future.







    #CardsJC STRENGTH Trial Journal Club







    Relevant disclosures: Dr. Matthew Budoff has funding from General Electric.







    Pearls • Notes • References • Guest Profiles • Production Team



















    CardioNerds Lipid Series PageCardioNerds Episode PageCardioNerds Academya href="https...

    • 33 Min.
    155. ACHD: Ebstein Anomaly with Dr. Jeannette Lin

    155. ACHD: Ebstein Anomaly with Dr. Jeannette Lin

    CardioNerds (Amit Goyal and Josh Saef) join ACHD fellow Dr. Prashanth Venkatesh and ACHD program director Dr. Jeannette Lin, both from the University of California, Los Angeles, for a deep dive into the complex disease entity that is Ebstein anomaly. They discuss the anatomic features of the dysplastic tricuspid valve as well as the right ventricle in patients with Ebstein anomaly, and how these structural features affect cardiovascular physiology and clinical presentation. This is followed by an in-depth discussion into associated entities including arrhythmias and atrial-level shunts as well as the appropriate multimodality evaluation. Finally, they tackle the difficult question of when and how to intervene, delving into the various interventional treatments and exploring their outcomes using illustrative case-based examples. Audio editing CardioNerds Academy Intern, Pace Wetstein.







    The CardioNerds Adult Congenital Heart Disease (ACHD) series provides a comprehensive curriculum to dive deep into the labyrinthine world of congenital heart disease with the aim of empowering every CardioNerd to help improve the lives of people living with congenital heart disease. This series is multi-institutional collaborative project made possible by contributions of stellar fellow leads and expert faculty from several programs, led by series co-chairs, Dr. Josh Saef, Dr. Agnes Koczo, and Dr. Dan Clark.







    The CardioNerds Adult Congenital Heart Disease Series is developed in collaboration with the Adult Congenital Heart Association, The CHiP Network, and Heart University. See more







    Claim free CME for enjoying this episode! Disclosures: None







    Pearls • Notes • References • Guest Profiles • Production Team



















    CardioNerds Adult Congenital Heart Disease PageCardioNerds Episode PageCardioNerds Academya href="https://www.cardionerds.

    • 1 Std. 10 Min.
    154. Cardiology vs Nephrology: A Diuretic Showdown with Dr. Michael Felker & Dr. Matt Sparks

    154. Cardiology vs Nephrology: A Diuretic Showdown with Dr. Michael Felker & Dr. Matt Sparks

    CardioNerds, Amit Goyal and Daniel Ambinder, join Duke University CardioNerds Ambassador and Correspondent, Dr. Kelly Arps for the diuretic showdown of a lifetime. Join us for this Cardiology vs. Nephrology discussion and respective approach to volume overload and diuretic strategies with Dr. Michael Felker (Professor of Medicine with tenure in the Division of Cardiology at Duke University School of Medicine), and Dr. Matt Sparks (Founding member of the Nephrology Social Medial Collective and #NephJC and Associate Professor of Medicine and Program Director for the Nephrology Fellowship Program at Duke University School of Medicine). Episode introduction, audio editing and Approach to Diuretic Resistance infographic by Dr. Gurleen Kaur (Director of the CardioNerds Internship).







    Volume overload is a common indication for hospitalization in patients with heart failure. Loop diuretics are first line therapy for volume overload in heart failure, with assessment for adequate response within 3-6 hours after administration. Elevation in creatinine is common with venous congestion as well as during decongestion. While other causes of renal injury should be considered, an elevated creatinine in this context should not automatically trigger avoidance or cessation of diuresis. Diuretic resistance is an exaggerated form of natural safety mechanisms in the face of diuresis. Strategies for addressing diuretic resistance include optimizing dose and frequency of loop diuretic administration, adding adjunctive medication for sequential nephron blockade (i.e., thiazide diuretic, potassium sparing diuretic, acetazolamide, tolvaptan, SGLT2 inhibitor), and, in refractory cases, hemodialysis with ultrafiltration. In the outpatient setting, transition to a more potent loop diuretic (i.e., torsemide or bumetanide from furosemide), addition of a mineralocorticoid antagonist, or intermittent dosing of thiazide diuretic may augment maintenance diuretic therapy for patients with diminished response to loop diuretics. 







    Check out the CardioNerds Failure Heart Success Series Page for more heart success episodes and content!







    Relevant disclosures: None







    Pearls • Notes • References • Guest Profiles • Production Team



















    CardioNerds Heart Success Series ...

    153. Case Report: Ur-Ine for a Treat – A Case of Diuretic Resistance – The Johns Hopkins Hospital

    153. Case Report: Ur-Ine for a Treat – A Case of Diuretic Resistance – The Johns Hopkins Hospital

    CardioNerds (Amit Goyal and Daniel Ambinder), join Dr. Anjali Wagle (Internal medicine resident, Johns Hopkins Hospital) and Dr. Nick Smith (Cardiology fellow, Johns Hopkins Hospital) for an important discussion involving a patient with non-ischemic dilated cardiomyopathy and biventricular heart failure who had developed diuretic resistance. They discuss the role for invasive hemodynamic assessment of volume overload, initial strategies in managing a patient with volume overload, the role of guideline directed therapy in the management of patients with recurrent volume overload, and advanced strategies for diuretic resistance. Dr. Nisha Gilotra (Director of the Cardiac Sarcoidosis Program and assistant professor of medicine, Johns Hopkins Hospital) provides the E-CPR for this episode. Audio editing and Approach to Diuretic Resistance infographic by Dr. Gurleen Kaur (Director of the CardioNerds Internship).











    This episode is made possible with support from Panacea Financial. Panacea Financial is a national digital bank built for doctors by doctors. Visit panaceafinancial.com today to open your free account and join the growing community of physicians nationwide who expect more from their bank. Panacea Financial is a division of Primis, member FDIC.























    Claim free CME just for enjoying this episode! Disclosures: NoneJump to: Patient summary - Case teaching - References



















    CardioNerds Case Reports PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll











    CardioNerds Journal Cluba rel="noreferrer noopener" href="http://eepurl.

    • 1 Std. 2 Min.
    152. Cardio-Obstetrics: Pregnancy and Multidisciplinary Critical Care with Drs. Afshan Hameed, Marie-Louise Meng, and Paul Forfia

    152. Cardio-Obstetrics: Pregnancy and Multidisciplinary Critical Care with Drs. Afshan Hameed, Marie-Louise Meng, and Paul Forfia

    CardioNerds (Amit Goyal and Daniel Ambinder), Cardio-OB series co-chair and University of Texas Southwestern Cardiology Fellow, Dr. Sonia Shah, episode lead fellow, Dr. Kaitlyn Ibrahim (Temple University now practicing with Lankenau Heart Group), join Dr. Afshan Hameed (Maternal-Fetal Medicine, Obstetrics & Gynecology, UC Irvine), Dr. Paul Forfia (Co-Director, Pulmonary Hypertension, Right Heart Failure & CTEPH Program, Temple University Hospital), and Dr. Marie-Louise Meng (Obstetric and Cardiothoracic Anesthesiology, Duke University) to discuss pregnancy and multidisciplinary critical care.







    Three experts from varied subspecialties including Cardiology, Pulmonary Hypertension, Maternal Fetal Medicine, Cardiac Anesthesia and Obstetrical Anesthesia guide listeners through a case of a patient with a congenital conotruncal ventricular septal defect, Eisenmenger physiology, and pulmonary hypertension who becomes pregnant. The discussion touches on pre-conception risk assessment, pulmonary hypertension medical therapy in pregnancy, maternal monitoring during pregnancy, development of detailed multidisciplinary delivery plans and accessibility of such plans, and peri- and post-partum multidisciplinary management of high-risk patients.







    Audio editing and episode introduction by CardioNerds Academy Intern, Christian Faaborg-Andersen.







    Pearls • Notes • References • Guest Profiles • Production Team



















    CardioNerds Cardio-Obstetrics Series PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll











    CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out C...

    • 1 Std. 6 Min.
    151. The Evolution Of The Neurohormonal Hypothesis With Dr. Milton Packer: Part 6 – Mentorship & The Secret to Immortality

    151. The Evolution Of The Neurohormonal Hypothesis With Dr. Milton Packer: Part 6 – Mentorship & The Secret to Immortality

    CardioNerds (Amit Goyal, Daniel Ambinder) and Dr. Mark Belkin, (CardioNerds Correspondent) and Dr. Shirlene Obuobi (CardioNerds Ambassador) from University of Chicago are honored to bring to you the Dr. Milton Packer perspective on the evolution of the neurohormonal hypothesis as part of The CardioNerds Heart Success Series.







    In part 6 Dr. Packer reflects on a conversation he had with Dr. Eugene Braunwald about mentorship and its role in immortality. This episode is particularly meaningful to the CardioNerds team as mentorship and sponsorship is such an important part of the CardioNerds mission.







    Check out the CardioNerds Heart Failure Success Series Page for more heart success episodes and content!







    This is a non CME episode. Disclosures: Milton Packer reports receiving consulting fees from Abbvie, Actavis, Amgen, Amarin, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Casana, CSL Behring, Cytokinetics, Johnson & Johnson Health Care Systems Inc., Eli Lilly and Company, Moderna, Novartis, ParatusRx, Pfizer, Relypsa, Salamandra, Synthetic Biologics, Teva Pharmaceuticals USA Inc. and Theravance Biopharma Inc.



















    CardioNerds Heart Failure Success Series PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll











    CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron!











    This CardioNerds Heart Failure Success Series was created in memory of Dr. David Taylor. We thank our partners at the Heart Failure Soci...

Kundenrezensionen

4,8 von 5
5 Bewertungen

5 Bewertungen

Top‑Podcasts in Gesundheit und Fitness

Das gefällt dir vielleicht auch